Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study

PURPOSE: Erythropoiesis-stimulating agents (ESAs) are often used in treatment of patients with chemotherapy-induced anemia. Many studies have demonstrated an improved hemoglobin (Hb) response when ESA is combined with intravenous iron supplementation and a higher effectiveness of intravenous iron ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Mafodda, Antonino, Giuffrida, D., Prestifilippo, A., Azzarello, D., Giannicola, R., Mare, M., Maisano, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527057/
https://www.ncbi.nlm.nih.gov/pubmed/28391437
http://dx.doi.org/10.1007/s00520-017-3690-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527057/
https://www.ncbi.nlm.nih.gov/pubmed/28391437
http://dx.doi.org/10.1007/s00520-017-3690-z

Ejemplares similares